The groundbreaking rise of Viagra has long been a example of pharmaceutical success, yet its future within the broader sector now presents questions about future gains. Copycat versions are eroding patent protection , causing worries that supporting companies significantly dependent to Viagra's former influence could be a problematic decision , esp